Metabomed lands $12.5 mln

Metabomed, a cancer metabolism company, has secured $12.5 million in funding.

Metabomed, a cancer metabolism company, has secured $12.5 million in funding. Yonjin Venture led the round with participation from return backers M Ventures, Pfizer Ventures, Pontifax Venture Fund, Boehringer Ingelheim Venture Fund and Arkin Bio Ventures.

Source: Press Release